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The vaccinia virus A20R protein is required for DNA replication, is associated with the processive form of the viral DNA
polymerase, and directly interacts with the viral proteins encoded by the D4R, D5R, and H5R open reading frames as
determined by a genome-wide yeast two-hybrid analysis. The purpose of the present study was to further analyze the latter
protein–protein interactions. Association of an epitope-tagged A20R protein with an epitope-tagged D4R or H5R protein,
expressed in vaccinia virus-infected cells, was demonstrated by binding the complex to one mAb followed by Western
blotting with another. Interaction between the A20R and D5R proteins, which was weakest in the yeast two-hybrid analysis,
could not be demonstrated by this method. A panel of N- and C-terminal truncated forms of the A20R protein was tested for
interaction with the D4R, H5R, and D5R proteins using the yeast two-hybrid system. These studies revealed that nonover-
lapping regions of A20R comprising amino acids 1 to 25, 26 to 76, and 201 to 251 were required for binding of D4R, H5R, and
D5R, respectively. By contrast, no interaction of A20R with D4R could be detected after deletion of only 25 codons from either
end of the latter open reading frame. A fusion protein containing either full-length A20R or only the N-terminal 25 amino acids
of A20R was sufficient to capture the D4R protein, whereas the fusion protein containing A20R amino acids 26 to 426 wass. The
DNA reINTRODUCTION
Poxviruses, of which vaccinia virus is the prototype,
are unique among DNA viruses in that they reproduce
exclusively in the cytoplasm of host cells and conse-
quently encode most of the enzymes and factors for
transcription and genome replication (Moss, 2001).
Many, but probably not all, of the proteins required for
viral RNA and DNA synthesis have been identified. Sev-
eral complementation groups of vaccinia virus tempera-
ture-sensitive (ts) mutants that express viral early pro-
teins but are impaired in DNA synthesis have been
isolated (Condit and Motyczka, 1981; McFadden and
Dales, 1980). One group was mapped to the E9L open
reading frame (ORF), which encodes the DNA polymer-
ase with a mass of 110 kDa, an associated 3 exonucle-
ase activity, and sequence similarities with other eukary-
otic and viral DNA polymerases (Challberg and Englund,
1979; Earl et al., 1986; Jones and Moss, 1984; McDonald
and Traktman, 1994; Sridhar and Condit, 1983; Traktman
et al., 1984). Another DNA replication-negative comple-
mentation group was mapped to the D4R ORF, which
1 Present address: Department of Virology II, National Institute of
Infectious Diseases, Tokyo, Japan.
2 To whom correspondence and reprint requests should be ad-
dressed at Laboratory of Viral Diseases, 4 Center Drive, MSC 045,0042-6822/02
232encodes a functional uracil DNA glycosylase (Ellison et
al., 1996; Millns et al., 1994; Stuart et al., 1993; Upton et
al., 1993). A third complementation group was mapped to
the D5R ORF, which encodes a nucleic acid independent
nucleoside triphosphatase (Evans et al., 1995; Evans and
Traktman, 1987, 1992). A fourth complementation group
was mapped to the B1R ORF, which encodes a serine-
threonine protein kinase that is packaged in virions (Ban-
ham and Smith, 1992; Lin et al., 1992; Rempel et al., 1990;
Rempel and Traktman, 1992; Traktman et al., 1989).
A role for a fifth viral protein in DNA replication was
suggested by the results of a vaccinia virus genome-
wide yeast two-hybrid screen (McCraith et al., 2000). The
A20R protein interacted with two proteins known to be
involved in DNA replication, D4R and D5R, and with the
H5R protein, which is a substrate of the B1R protein
kinase (Beaud et al., 1995) and has one or more roles in
transcription (Black et al., 1998; Kovacs and Moss, 1996)
and virus assembly (DeMasi and Traktman, 2000). More
direct evidence for the role of the A20R protein was
obtained by Traktman and co-workers (Klemperer et al.,
2001), who identified this protein as a previously de-
scribed component of the processive form of DNA poly-
merase (McDonald et al., 1997). Subsequently, directed
mutagenesis of the A20R ORF was used to isolate con-
ditional lethal ts mutants that are blocked in viral DNAnot, confirming the results of the yeast two-hybrid analysi
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replication (Ishii and Moss, 2001; Punjabi et al., 2001).
Taken together these data suggest that the A20R protein
could be a key element of a multiprotein DNA replication
complex that includes the DNA polymerase, the D4R and
D5R proteins, and possibly the H5R protein. For A20R to
assemble such a complex, however, the sites for inter-
action with the other proteins must be nonoverlapping.
The purpose of the present work was to confirm and
further dissect the interactions between the A20R and
the D4R, D5R, and H5R proteins.
RESULTS
Interactions of the A20R protein in vaccinia
virus-infected cells
We used an independent method to confirm the inter-
actions of the A20R protein with the D4R, D5R, and H5R
proteins, which had been determined with the yeast
two-hybrid system. BS-C-1 cells were infected with
vTF7-3, a recombinant vaccinia virus that expresses the
bacteriophage T7 RNA polymerase (Fuerst et al., 1986)
and then transfected with one or two plasmids contain-
ing a T7 promoter regulating the V5 epitope-tagged A20R
ORF or influenza virus hemagglutinin (HA) epitope-
tagged D4R, D5R, or H5R ORFs. When extracts of cells
that had expressed V5-A20R alone or coexpressed V5-
A20R and HA-D4R were analyzed directly by Western
blotting with V5 monoclonal antibody (mAb), a doublet
band corresponding to the 49-kDa V5-A20R protein was
visualized (Fig. 1A, Lanes 2, 3). When lysates of cells that
had expressed HA-D4R and V5-A20R proteins were first
incubated with HA mAb and the bound proteins exam-
ined by Western blotting with the V5 mAb, the V5-A20R
protein was easily detected (Fig. 1A, Lane 7). In contrast,
the protein was visible only as a faint background band
in lysates of cells that had expressed V5-A20R alone (Fig.
1A, Lane 6). Thus, the complex of V5-A20R and HA-D4R
was captured by the HA mAb. An additional protein with
an estimated mass of greater than 75 kDa was detected
by Western blotting in all lanes including controls, indi-
cating that it is unrelated to either A20R or D4R expres-
sion. The V5-A20R-HA-D4R complex could also be cap-
tured with V5 mAb, although the band intensity was
weaker on Western blotting with the HA mAb than with
the V5 mAb (data not shown).
We used the same procedure to analyze the interac-
tion of A20R with the H5R and D5R proteins. When
V5-A20R and HA-H5R were coexpressed, the complex
captured by the HA MAb contained the V5-A20R protein
as detected by Western blotting with V5 mAb (Fig. 1B,
Lane 7). Similarly, the complex captured by the V5 mAb
contained the HA-H5R protein as detected by Western
blotting with the HA mAb, although the band was fainter
(data not shown). The signal detected by Western blot-
ting was weaker for the A20R–H5R interaction than for
the A20R–D4R interaction. Moreover, no interaction
could be detected between epitope-tagged A20R and
D5R proteins by this procedure (data not shown). The
relative strengths of the interactions determined by bind-
ing of the complex to mAbs corresponded with the yeast
two-hybrid analysis in which the sizes of the diploid
yeast colonies in selective medium were A20R-D4R 
A20R-H5R  A20R-D5R (McCraith et al., 2000).
Analysis of the A20R-binding domains using the yeast
two-hybrid system
To identify regions of the A20R protein required for its
interaction with D4R, H5R, and D5R proteins, we fused
C-terminal and N-terminal truncated A20R ORFs with the
GAL4-binding domain. The ability of a panel of these
constructs to interact with D4R fused to the activation
domain was tested in the yeast two-hybrid system. Ini-
tially, the results were scored as positive or negative
based on colony growth under selection conditions and
a filter lift assay for -galactosidase. Using the C-termi-
nal truncation set (Fig. 2), we observed an interaction
even when only the N-terminal 1 to 25 amino acids
remained. Complementing this, removal of 25 or 100
amino acids from the N-terminus of A20R prevented the
interaction with the D4R protein. To quantify the interac-
tions, the yeast two-hybrid experiments were repeated
using a liquid -galactosidase assay. In Fig. 2, the data
are presented as the percentage of -galactosidase pro-
duced with the full-length A20R protein. With the fusion
protein containing 1 to 50 N-terminal amino acids of
A20R, the activity was even higher than with full-length,
FIG. 1. Detection of protein–protein interactions by co-immunopre-
cipitation. Monolayers of BS-C-1 cells were infected with vTF7-3 and
transfected or cotransfected with pCRV5A20R (V5-A20R), pCRHAD4R
(HA-D4R), or pCRHAH5R (HA-H5R). After 24 h, the cells were harvested
and cleared lysates were analyzed directly or incubated with anti-HA
mAb followed by Protein A–Sepharose. The bound proteins were sep-
arated by SDS–PAGE and transferred to nitrocellulose for Western
analysis with V5 mAb. Keys to the lanes are shown below the autora-
diographs. The positions and masses in kDa of marker proteins are
indicated on the right.
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whereas lower but still reproducible activity was ob-
tained with only 1 to 25 N-terminal amino acids (Fig. 2).
These data indicated that the minimal binding region for
the D4R protein is within the N-terminal 25 amino acids
of A20R, although for optimal binding it may extend
somewhat further.
Similar studies were used to analyze the interactions
of fusion proteins containing A20R truncations with the
H5R protein. Again, the results were first scored as
positive or negative by colony formation under selection
conditions and a filter lift assay for -galactosidase. We
found interactions of all C-terminal truncations that re-
tained 76 or more N-terminal amino acids but not when
only 50 N-terminal amino acids remained. The panel of
N-terminal truncations of A20R was also tested. Interac-
tion with H5R still occurred when 25 amino acids were
removed but not when 100 amino acids were removed.
These results were confirmed using the liquid -galac-
tosidase assay (Fig. 3). The fusion protein containing
only 76 N-terminal amino acids retained about half of the
full-length activity, whereas background activity was ob-
tained with only 50 N-terminal amino acids (Fig. 3). In
addition, the fusion protein containing amino acids 26 to
426 retained activity (Fig. 3). Taken together these results
suggested that the minimal binding region for the H5R
protein is between the N-terminal 26 to 76 amino acids of
A20R.
The different results obtained with D4R and H5R pro-
teins provided an internal control. Since the N-terminal 1
to 50 amino acids of A20R mediated binding to D4R, the
failure of the same construct to bind to H5R could not be
due to poor expression or instability. Likewise, the dele-
FIG. 2. Mapping the D4R-binding site of the A20R protein by yeast two-hybrid analysis. The full-length A20R ORF is shown at the top with amino
acid numbers below. The filled box indicates the deduced D4R minimal binding region. Representations of the complete A20R ORF and truncated
versions expressed in the yeast two-hybrid system are shown as bars. Segments of the A20R ORF are defined by the amino acid numbers indicated
on the right. The expression of lacZ, resulting from the activation of a GAL4-dependent lacZ gene, is shown on the left. The value obtained using the
full-length A20R ORF was defined as 100%.
FIG. 3. Mapping the H5R-binding site of the A20R protein by yeast two-hybrid analysis. The full-length A20R ORF is shown at the top with amino
acid numbers below. The filled box indicates the deduced H5R minimal binding region. Representations of the complete A20R ORF and truncated
versions expressed in the yeast two-hybrid system are shown as bars. Segments of the A20R ORF are defined by the amino acid numbers indicated
on the right. The expression of lacZ, resulting from the activation of a GAL4-dependent lacZ gene, is shown on the left. The value obtained using the
full-length A20R ORF was defined as 100%.
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tion of the N-terminal 25 amino acids of A20R did not
prevent binding to H5R and therefore failure of this con-
struct to bind D4R could not be attributed to trivial rea-
sons.
The same panel of A20R truncations was used to
analyze binding to the D5R protein (Fig. 4). The fusion
protein containing the N-terminal 1 to 251 amino acids of
A20R retained binding activity, whereas one containing 1
to 226 amino acids did not. Activity was retained after
deletion of the N-terminal 100 amino acids and was
weaker but detectable after deletion of 200 amino acids.
The liquid -galactosidase assay was not sensitive
enough to quantify the interaction of the A20R and D5R
proteins and therefore photographs of colonies that
formed in histidine-deficient medium are shown in Fig. 4.
These results suggested that the minimal interaction
region for D5R occurs between amino acids 200 and 250
of A20R.
We also tried to map the site on the D4R protein that is
necessary for binding A20R. Four D4R truncations were
made in which either 25 or 100 amino acids were deleted
from the N- or C-terminal end. However, none of the D4R
truncated proteins exhibited a detectable interaction with
A20R.
Analysis of the A20R-binding domains using maltose-
binding protein (MBP) fusions
We prepared fusions of the MBP with full-length and
truncated forms of the A20R protein to confirm results
obtained in the yeast two-hybrid analysis. Radioactively
labeled D4R, D5R, and H5R proteins were synthesized in
rabbit reticulocyte lysates. In each case, the predominant
radioactive band detected by SDS–PAGE and autora-
diography was of the expected size and expressed only
with the appropriate template (data not shown). The MBP
fusion proteins were immobilized on amylose resin and
incubated with the in vitro synthesized D4R, D5R, or H5R
protein. The D4R protein bound to full-length MBP-A20R
protein and to the fusion containing only the N-terminal
25 amino acids of A20R. Although only a small percent-
age of the D4R protein applied to the resin was recov-
ered after the extensive washing steps, the binding was
specific as none bound either to the MPB fusion pro-
duced with amino acids 26 to 426 of A20R or to MPB
alone (Fig. 5). Curiously, radioactively labeled bands that
were minor components of the total translation mixture
were concentrated by absorption to the amylose resin.
However, these bands were present in similar amounts
regardless of whether MPB or MPB-A20R proteins were
FIG. 4. Mapping the D5R binding site of the A20R protein by yeast two-hybrid analysis. The full-length A20R ORF is shown at the top with amino
acid numbers below. The filled box indicates the deduced D5R minimal binding region. Representations of the complete A20R ORF and truncated
versions expressed in the yeast two-hybrid system are shown as bars. Segments of the A20R ORF are defined by the amino acid numbers indicated
on the right. Positive interactions are indicated by growth of yeast on His plates as shown on the left.
FIG. 5. Pull-down experiment demonstrating the interaction of full-
length and truncated A20R fusion proteins with the D4R protein. Seg-
ments of the A20R ORF representing amino acids 1 to 426 (full length),
1 to 25, and 26 to 426 were expressed as MBP fusions and bound to
amylose resin. As a control, MBP was expressed without A20R se-
quences and also bound to resin. An in vitro transcription-translation
system was used to synthesize radioactively labeled D4R protein. A
20-l sample was diluted with 200 l of binding buffer, incubated with
immobilized MPB fusion protein, and extensively washed. The bound
proteins were eluted in 40 l SDS buffer and 20 l was analyzed by
SDS–PAGE. Lane 1, MPB-A20R (1 to 426); Lane 2, MPB-A20R (1 to 25);
Lane 3, MBP-A20R (26 to 426); Lane 4; MBP. Lane 5 contained 0.5 l of
the total in vitro translation reaction.
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immobilized. Thus, we concluded that the first 25 amino
acids of the A20R protein are both necessary and suffi-
cient for binding the D4R protein. We failed, however, to
show the interaction between A20R and D5R, A20R and
H5R with this pull-down system, presumably because
the interactions were not stable enough to withstand the
resin washing steps.
DISCUSSION
The interactions of the vaccinia virus A20R protein
with the D4R, D5R, and H5R proteins were discovered
during a genome-wide yeast two-hybrid analysis (Mc-
Craith et al., 2000). Because the D4R and D5R proteins
are involved in viral DNA synthesis, these data sug-
gested that the A20R protein is associated with the DNA
replication complex. More direct evidence for this idea
came from the finding that the A20R protein is associated
with the processive form of viral DNA polymerase iso-
lated from infected cells (Klemperer et al., 2001). The
latter authors (Klemperer et al., 2001) suggested that the
failure of the yeast two-hybrid screen to detect an inter-
action of the A20R protein with DNA polymerase could
have been due to the presence of a yeast transcriptional
terminator within the polymerase ORF. As synthesis of
the DNA polymerase in the yeast system was not inves-
tigated and no interactions with the DNA polymerase
were detected, the suggested explanation or another in
which the DNA polymerase was not expressed well in
yeast seems likely. However, the possibility remains that
association of the A20R protein with DNA polymerase is
mediated through binding to some intermediate protein
such as D4R, H5R, or D5R.
In the first part of the present study, we confirmed the
interaction of D4R and H5R proteins with the A20R pro-
tein by co-immunoprecipitation from lysates of vaccinia
virus infected cells. Our failure to detect co-immunopre-
cipitation of the A20R protein with the D5R protein is
likely due to the weakness of the interaction, since this
was also the weakest of the A20R interaction in the yeast
two-hybrid system. We cannot exclude the possibility,
however, that the epitope tag on the D5R protein dimin-
ished the interaction.
The major emphasis of the present study was map-
ping the protein–protein interaction domains of the A20R
ORF. This was achieved by employing a panel of A20R N-
and C-terminal truncations in the yeast two-hybrid sys-
tem. These studies revealed that the N-terminal 25
amino acids of A20R are necessary and sufficient for
interaction with the D4R protein, although binding might
be more efficient with additional amino acids. The ability
of the 25 amino acid N-terminal domain fused with MPB
to mediate binding to the D4R protein was demonstrated
by a pull-down experiment, confirming the interaction.
Additional yeast two-hybrid analyses suggested that the
minimal A20R-binding domain is between amino acids
26 and 76 for the H5R protein and between amino acids
201 and 251 for the D5R protein, although these could not
be evaluated by pull down. Attempts to use a similar
yeast two-hybrid strategy to map the site on D4R that
interacts with A20R, however, was unsuccessful as de-
letion of only 25 amino acids from either end abrogated
binding.
Recently, A20R ts mutants were constructed by sub-
stituting alanine residues for clusters of charged amino
acids (Ishii and Moss, 2001; Punjabi et al., 2001). Such
clusters could be involved in inter- as well as intraprotein
interactions. There are three charged clusters within the
determined binding region of A20R for D5R. Of these,
mutants with alanine substitutions of two clusters could
not be isolated, suggesting lethality and the mutant with
substitution of the third cluster had the most stringent
temperature sensitivity and grew poorly even at the per-
missive temperature. There was no charged cluster
within the determined D4R-binding region and substitu-
tions of the one within the H5R-binding region did not
alter the plaque phenotype or temperature sensitivity. A
multiple alignment analysis showed considerable amino
acid identity between the D4R binding region of A20R
orthologs of all chordopoxviruses. However, at this time
we do not know whether the amino acid identities rep-
resent contact sites between A20R and D4R or con-
served structural features. Nor do we know whether the
A20R orthologs can bind vaccinia virus D4R or exhibit
species or genus specificity.
In summary, we have confirmed and extended previ-
ous studies demonstrating the interaction of the A20R
protein with at least three proteins, namely D4R, D5R,
and H5R. Because the determined binding domains for
the D4R, D5R, and H5R proteins do not overlap, the A20R
protein may play an important role in forming or stabiliz-
ing the DNA replication complex.
MATERIALS AND METHODS
Plasmid constructions
pVOTED4R, pVOTED5R, and pVOTEH5R were con-
structed by PCR amplification of the D4R, D5R, and H5R
ORF from vaccinia virus WR DNA using the primers:
D4R-fN: AACCATGGATTCAGTGACTGTATCACA
D4R-r: AAGGATTCTTAATAAATAAACCCTTGAG
D5R-fN: AACCATGGATGCGGCTATTAGAGGTAAT
D5R-r: AAGGATTCTTACGGAGATGAAATATCCT
H5R-fN: AACCATGGCGTGGTCAATTACAAATAAA
H5R-r: AAGGATTCTTACTTCTTACAAGTTTTAA
The PCR products were cleaved with NcoI and BamHI
and cloned into the NcoI, BamHI-cleaved pVOTE1 vector
(Ward et al., 1995).
pCRV5A20R, pCRHAD4R, pCRHAD5R, and pCRHAH5R
were constructed by PCR amplification of the A20R, D4R,
D5R, and H5R ORFs from vaccinia virus strain Western
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Reserve (WR) DNA using the primers D4R-r, D5R-r, and
H5R-r shown above and the additional primers:
A20R-fV5: AAATGGGTAAGCCTATCCCTAACCCTCTC-
CTCGGTCTCGATTCTACGACTTCTAGCGCTGATTTAACT-
AACTTAAAA
A20R-r: AAGGATCCTCACTCGAATAATCTTTTTT
D4R-fHA: AAATGTATCCATATGATGTTCCAGACTATGC-
TAATTCAGTGACTGTATCACACGCGCCATAT
D5R-fHA: AAATGTATCCATATGATGTTCCAGACTATGC-
TGATGCGGCTA TTAGAGGTAATGATGTTATC
H5R-fHA: AAATGTATCCATATGATGTTCCAGACTATGC-
TGCGTGGTCAATTACAAATAAAGCGGATACT
The PCR products were ligated to pCR3.1 vector by
using the eukaryotic TA Cloning Kit (Invitrogen/Life Tech-
nologies).
pGADD4R, pGADD5R, and pGADH5R were con-
structed by PCR amplification of the D4R, D5R, and H5R
ORF from vaccinia virus WR DNA using the primers
D4R-r, D5R-r, and H5R-r shown above and the additional
primers:
D4R-fE: AAGAATTCATGAATTCAGTGACTGTATC
D5R-fE: AAGAATTCATGGATGCGGCTATTAGAGG
H5R-fE: AAGAATTCATGGCGTGGTCAATTACAAA
The PCR products were cleaved with EcoRI and
BamHI and cloned into the EcoRI, BamHI-cleaved pGAD
vector (Clontech).
pACTD5R and pACTH5R were constructed by PCR
amplification of the D5R and H5R ORF from vaccinia
virus WR DNA using primers shown in the methods
describing construction of pVOTE derivatives. To create
pACTD5R and pACTH5R, the PCR products were cleaved
with NcoI and BamHI and cloned into the NcoI, BamHI-
cleaved pACT vector (Clontech).
pASA20R and related plasmids containing truncations
of the A20R ORF were constructed by PCR amplification
of the A20R ORF from vaccinia virus WR DNA using the
primers:
A20R-f: AAGAATTCATGACTTCTAGCGCTGATTT
A20R-r: AAGGATCCTCACTCGAATAATCTTTTTT
A20R-f25: AAGAATTCGCGGCTATAGAAAAGTATAA
A20R-f50: AAGAATTCGCTAATGTCGAGACGTCAATA
A20R-f100: AAGAATTCGGAAACTCTTTTCAAATACC
A20R-f150: AAGAATTCATATTTAAACTAGCTAGTGAG-
TAC
A20R-f200: AAGAATTCAAGTTGGGAGAACTTAGGCG-
GCAA
A20R-r326: AAGGATCCTCACTCATTAATATCTAATTTAT
A20R-r276: AAGGATCCTCAATTAATATCTAATTTATTA-
GTC
A20R-r251: AAGGATCCTCAGTCTACATCTTTTACTA-
ATATC
A20R-r226: AAGGATCCTCAACGATCTACCTTGATGGA-
CTC
A20R-r126: AAGGATCCTCACAGAAAGTCTATTCCGT-
TAT
A20R-r75: AAGGATCCTCAGTAATAGCCCGGATCAATAT
A20R-r50: AAGGATCCTCATACCTTTTGCACGCCTATT
A20R-r25: AAGGATCCTCAAGAATCTGAAAATTTCAAA
For yeast two-hybrid analysis, PCR fragments of A20R
ORFs with N-terminal truncations were amplified by us-
ing one of A20R-fs and A20R-r, and those with C-terminal
truncations were amplified by using one of A20R-rs and
A20R-f. The PCR products were cleaved with EcoRI and
BamHI and cloned into the EcoRI, BamHI-cleaved pAS
vector (Clontech).
To make MBP fusions, PCR fragments of the vaccinia virus
entire A20R coding sequence, coding sequence of N-terminal
25 amino acids of A20R, and coding sequence of C-terminal
400 amino acids of A20R were amplified by using sets of
primers A20R-f and A20R-r, A20R-f and A20R-r25, and A20-f25
and A20-r, respectively. These fragments were digested with
EcoRI and BamHI and inserted in-frame downstream of MBP
sequences in the vector pMALc2 (New England Biolabs),
yielding pMALc2A20R, pMALc2A20R-1/25, and pMALc2A20R-
26/426, respectively.
In all cases, cloned genes were sequenced to confirm
the fidelity of the PCR reactions.
Yeast strains and transformation
Yeast strains Y187 and HF7C were used for transfor-
mation of Gal4-BD fusion proteins and Gal4-binding do-
main fusion proteins. The yeast strains were maintained
at 30°C on Yeast extract, Peptone, Dextrose (YPD) plates.
Transformation was performed as described in the Clon-
tech Matchmaker System manual. Briefly, a stationary-
phase yeast culture was diluted into 30 ml YPD medium
to an optical density at 600 nm (OD600) of between 0.2
and 0.3 and grown for 3 h at 30°C. To prepare competent
yeast, cells were collected by centrifugation at 1000 g for
5 min at room temperature, washed once with H2O, and
suspended in 1.5 ml of 1 TE-LiAc (10 TE is 0.1 M
Tris–HCl plus 10 mM EDTA, pH 7.5; 10 LiAc is 1 M LiAc,
pH 7.5). For small-scale cotransformation, 0.5 g of each
DNA and 100 g of herring sperm carrier DNA were
mixed with 100 l of competent yeast cells. After adding
600 l of a polyethylene glycol (PEG)-LiAc solution (1
LiAc, 1 TE, 40% PEG 4000), the mix was incubated at
30°C for 0.5 h. Cells were then added to 70 l dimethyl
sulfoxide and incubated at 42°C for 15 min. The cells
were then collected by centrifugation and suspended in
1 TE for selection on Leu Trp SD (Minimal Synthetic
Dropout) plates.
Filter lift assay for -galactosidase activity in yeast
two-hybrid system
The yeast strain Y187 was used for this assay. Four to
six days after transformation, the yeast colonies were
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lifted onto filter paper (VWR, West Chester, PA), and the
cells were lysed by freezing at 80°C for 20 min and
thawing at room temperature. The filter disks were
placed onto filter paper soaked in 2 ml of Z-buffer (60 mM
Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4,
0.3%-mercaptoethanol) containing 0.33 mg 5-bromo-4-
chloro-3-indolyl-D-galactopyranoside (X-Gal) per milliliter
and incubated at 37°C for 1 to 3 h.
Liquid -galactosidase assay in yeast two-hybrid
system
Individual yeast colonies were transferred into 3 ml of
Leu Trp SD medium and grown to stationary phase. They
were then diluted 1:10 in medium and grown to A600 of
between 0.4 and 0.6. The cells were collected by centrif-
ugation at 1500 g for 5 min at 4°C and washed once with
Z-buffer. The cell pellets were suspended in 250 l of
Z-buffer, and the cells were lysed following addition of
200 l of ice-cold acid-washed glass beads by vortexing
three times for 1 min each. The cell lysates were clarified
by centrifugation at 3000 g for 5 min at 4°C. Total protein
concentrations were determined by the method of Brad-
ford (1976). For -galactosidase assays, 200 l of
4-mg/ml o-nitrophenyl-D-galactopyranoside (ONPG) was
added to 150 l of cell extract diluted in 800 l of
Z-buffer, and the mixture was incubated at 30°C until a
pale yellow color developed. The reaction was stopped
by adding 500 l of 1 M Na2CO3, and the A420 was
determined. Z-buffer alone incubated with ONPG was
used as a control for measuring OD420.
HIS3 assay
The yeast strain HF7C was used and the presence of
an interaction between two proteins was indicated by the
activation of the reporter genes HIS3, which allow for
growth on medium lacking histidine. Colonies grown on
SD/-Leu/-Trp plates were streaked on SD/-Leu/-trp/-His
plates and growth on the plates was checked as de-
scribed in the Matchmaker Library protocol (Clontech).
Overexpression and purification of MBP-fused A20R
proteins
Bacterial synthesis of recombinant A20R was carried
out with the T7 RNA polymerase expression system
(Rosenberg et al., 1987). Escherichia coli strain BL-
21(DE3) pLysS was transformed with pMALc2A20R and
transformants were grown in LB broth plus 100 g of
ampicillin per milliliter. Expression of recombinant pro-
teins was induced with 0.4 mM isopropyl thiogalactoside
for 2 to 3 h. A 10-ml culture of induced bacteria was
centrifuged and the pellet was suspended in 0.01 M
Tris–HCl, pH 7.5 containing 0.15 M NaCl, 1% sodium
deoxycholate, 1% NP-40, 0.1% SDS (RIPA buffer). Bacteria
were disrupted by four freeze-thaw cycles and the sus-
pension was then forced through a 20-gauge needle to
shear the bacterial DNA. Further steps were carried out
at 4°C. The insoluble residue was removed by centrifu-
gation at 100,000 g for 45 min, and the supernatant was
mixed with 0.5 ml of amylose resin (New England Bio-
Labs) for 2 h at 4°C. The suspension was centrifuged
and the supernatant was discarded. The resin was
washed five times with RIPA and used as the A20R-
immobilized resin.
Coupled in vitro transcription and translation
The D4R, D5R, and H5R proteins were synthesized in
vitro using the TnT Quick-coupled reticulocyte lysate
system (Promega). Briefly, pVOTED4R, pVOTED5R, and
pVOTEH5R, regulated by a T7 promoter, were used to
program the in vitro transcription/translation reaction.
Supercoiled plasmid DNA was added at 0.5–1.0 g per
100 l reaction and the mixture was incubated with 50 l
TnT Quick Lysate (Promega), 5 mCi Redivue Pro-Mix 35S
(Amersham), and incubated for 2 h at 30°C. Aliquots (20
l) of the reaction mixture were diluted to 200 l with
RIPA buffer, mixed with 20 l of MPB-A20R-immobilized
resin, and incubated overnight at 4°C. The suspension
was centrifuged and the supernatant was discarded. The
resin was washed five times with RIPA, boiled in SDS
loading buffer, and analyzed by SDS–PAGE using 4–20%
separating gels. Gels were dried and autoradiographed.
Immune complexes and Western blot analysis
Confluent monolayers of BS-C-1 cells in 35-mm dishes
were infected with vTF7-3 at a multiplicity of 10 and
incubated at 37°C for 2 h. Infected cells were transfected
with 0.5 g of pCRV5A20R and 0.5 g of either
pCRHAD4R or pCRHAD5R or pCRHAH5R in Lipo-
fectamine (Invitrogen/Life Technologies) and incubated
at 37°C for 22 h. Cells were harvested in lysis buffer (50
mM Tris–HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 1 mg/ml
aprotinin; Aldrich). The lysates were frozen and thawed
and then clarified by centrifugation for 10 min at 15,000
rpm at 4°C. Clarified lysates were incubated with anti-HA
(Covance) or anti-V5 (Invitrogen) mAb for 2 h at 4°C with
rotation. Protein A–Sepharose was added for 2 h at 4°C.
The immune complexes were harvested by centrifuga-
tion and washed three times with lysis buffer. Samples
were suspended in SDS loading buffer, boiled, and an-
alyzed by SDS–PAGE using 4–20% gradient separating
gels. The proteins were transferred to nitrocellulose in 25
mM Tris–HCl, 192 mM glycine, 20% methanol for 1 h at
4°C. Nitrocellulose filters were incubated with primary
mAb, and the bound mAb was detected using polyclonal
anti-mouse horseradish peroxidase-conjugated antibody
(1:5000; Amersham). Supersignal West Pico Chemilumi-
nescence Substrates (Pierce) were used as described by
the manufacturer.
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